Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Astrana HealthASTH -3.00%81 Revenue per Share is $71.42 as of Mar. 2026. GuruFocus rates ASTH with a GF Score™ of 81/100 and a GF Value™ of $83.77 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 612 Healthcare Providers & Services companies, Astrana Health ranks better than 91.83% on this metric.
Astrana Health's revenue per share for the
three
months ended in Mar. 2026 was $19.67.
Astrana Health's revenue per share for the trailing twelve months (TTM) ended in Mar. 2026 was $71.42.
During the past 12 months, the average Revenue Per Share Growth Rate of Astrana Health was 53.20% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 37.00% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 42.00% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 23.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Astrana Health's Revenue per Share or its related term are showing as below:
ASTH'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 1.3 Med: 34.9 Max: 62.1
Current: 37
During the past 13 years, Astrana Health's highest 3-Year average Revenue Per Share Growth Rate was 62.10% per year. The lowest was 1.30% per year. And the median was 34.90% per year.
ASTH's 3-Year Revenue Growth Rate is ranked better than 91.83% of 612
companies
in the Healthcare Providers & Services industry
Industry Median: 6.9
vs ASTH: 37.00
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Astrana Health Revenue per Share Related Terms
Astrana Health Revenue per Share Historical Data
* Premium members only.
The historical data trend for Astrana Health's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASTH vs SNDA, SGRY, AVAH: Revenue per Share Comparison
For the Medical Care Facilities subindustry, Astrana Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Astrana Health's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Astrana Health's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $71.42
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astrana Health (ASTH) has a Revenue per Share of $71.42 as of Mar. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Astrana Health and its competitors. According to the industry distribution chart, Astrana Health ranks #50 out of 612 companies in the Healthcare Providers & Services industry, placing it in the top 8.2%.
Is Astrana Health's Revenue per Share too high?
Astrana Health's current Revenue per Share is $71.42. The Healthcare Providers & Services industry median Revenue per Share is 6.90. Astrana Health's value of $71.42 is 935.1% above this industry median. Based on the distribution chart, Astrana Health ranks #50 out of 612 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Astrana Health has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Revenue per Share compare to SNDA and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #50 out of 612 companies for Revenue per Share. This places Astrana Health in the top 8% of its industry — outperforming the majority of peers. The industry median Revenue per Share is 6.90. Astrana Health's value of $71.42 is 935.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Healthcare Providers & Services company?
The median Revenue per Share among Healthcare Providers & Services companies is 6.90, based on 612 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current Revenue per Share of $71.42 is 935.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median Revenue per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current Revenue per Share is $71.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $83.77, compared to a current price of $35.52 — trading 57.6% below its estimated fair value. The current Revenue per Share is $71.42 and 935.1% above the Healthcare Providers & Services industry median of 6.90. Astrana Health's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Astrana Health (ASTH), the current Revenue per Share is $71.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (ASTH) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of $35.52 is trading 57.6% below its estimated GF Value™ of $83.77.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for ASTH:
Revenue per Share: $71.42
GF Value™: $83.77 vs. price of $35.52 (57.6% below fair value)
Industry Position: 935.1% above the Healthcare Providers & Services median (#50 of 612)
No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
81GF Score
Get the complete analysis for ASTH
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASTH has been successfully added to your 
